Does aspirin reduce recurrence after completing anticoagulant treatment for an idiopathic thromboembolic event?
Resumen La enfermedad tromboembólica idiopática presenta un alto riesgo de recurrencia. Existe controversia respecto a la utilidad de la aspirina para disminuir la recurrencia luego de haber completado el tratamiento anticoagulante. Utilizando la base de datos Epistemonikos, la cual es mantenida me...
Main Authors: | Andrés Valenzuela, Andrés Aizman |
---|---|
Format: | Article |
Language: | English |
Published: |
Medwave Estudios Limitada
2015-04-01
|
Series: | Medwave |
Online Access: | http://www.medwave.cl/link.cgi/Medwave/PuestaDia/ResEpis/6118 |
Similar Items
-
Does aspirin have a role in preventing unprovoked recurrent thromboembolism?
by: Yenny Yenny
Published: (2015-12-01) -
Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease?
by: Juan Pablo Albornoz, et al.
Published: (2015-12-01) -
Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
by: Paul E Marik, et al.
Published: (2015-01-01) -
Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis
by: Sobieraj, Diana M., et al.
Published: (2015) -
The prediction role of D-dimer in recurrence of venous thromboembolism 1-year after anticoagulation discontinuing following idiopathic deep vein thrombosis
by: Babak Tamizifar, et al.
Published: (2014-01-01)